Antigen Test Rates At Train Stations Dropped To IDR 35,000

Illustration-(Photo: DOK ANTARA)

JAKARTA - PT Kereta Api Indonesia (Persero) Daop 1 Jakarta has implemented a new tariff for the rapid antigen test service at the station, from Rp. 45 thousand to Rp. 35 thousand. The new rates are effective from Saturday, January 1st.

"We continue to improve services to train customers, especially long-distance trains (KAJJ)," said Head of Public Relations of KAI Daop 1 Jakarta Eva Chairunisa in a statement in Jakarta, Antara.

As for the requirements for those who want to do an antigen test at the station, prospective users must already have a ticket booking code. If after the antigen process you get a positive result, the ticket fee can be returned 100 percent in cash at the station counter.

In the area of KAI Daop 1 Jakarta, since the beginning of the Nataru period, starting on December 17, 2021, until now, around 80,000 prospective service users have utilized the antigen test service at the station.

The following are 5 stations that serve antigen rapid tests in the Daop 1 Jakarta area:

- Gambir Station: 06.00 to 21.00 WIB

- Pasarsenen Station: 05.00 to 22.30 WIB

- Bekasi Station: 09.00 to 18.00 WIB

- Karawang Station: 08.30 to 17.30 WIB

- Cikampek Station: 09.30 to 18.30 WIB

Eva continued that KAI Daop 1 Jakarta continues to appeal to prospective passengers to pay attention to and complete the requirements for boarding the KAJJ during the 2021 Christmas and New Year 2022 (Nataru) holidays, one of which is a negative rapid antigen test result for prospective passengers over the age of 12.

Prospective passengers who carry out antigens at the station are also advised that the process be carried out on D-1 or one day before the scheduled departure.

"With the increasingly affordable price of antigen, it is hoped that prospective passengers can take advantage of the rapid antigen test service in completing the requirements according to the health protocol that has been set," he said.

He added that the presence of an antigen test service at the station was the result of a BUMN synergy between KAI and Rajawali Nusantara Indonesia through its subsidiary, Rajawali Nusindo, Indofarma through its subsidiary, Farmalab, and other parties.

PT KAI always follows and complies with all regulations from the government in order to prevent the spread of Covid-19 on the train mode of transportation.

"For people who want to use train services during the 2021/2022 Nataru period, they can order train tickets through the KAI Access application, the KAI website, and all other official KAI ticket sales channels," he concluded.